您的购物车当前为空
T-5224 是选择性的转录因子 c-Fos/activator protein (AP)-1 抑制剂,具有抗炎作用。T-5224 能够特异性抑制 c-Fos/c-Jun 的 DNA 结合活性,抑制 IL-1β 诱导的 Mmp-3、Mmp-13、Adamts-5 转录上调,但对其他转录因子的结合活性无影响。T-5224 可用于类风湿关节炎、骨关节炎、软骨退变研究。
T-5224 是选择性的转录因子 c-Fos/activator protein (AP)-1 抑制剂,具有抗炎作用。T-5224 能够特异性抑制 c-Fos/c-Jun 的 DNA 结合活性,抑制 IL-1β 诱导的 Mmp-3、Mmp-13、Adamts-5 转录上调,但对其他转录因子的结合活性无影响。T-5224 可用于类风湿关节炎、骨关节炎、软骨退变研究。


为众多的药物研发团队赋能,
让新药发现更简单!
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 378 | 现货 | |
| 2 mg | ¥ 548 | 现货 | |
| 5 mg | ¥ 888 | 现货 | |
| 10 mg | ¥ 1,330 | 现货 | |
| 25 mg | ¥ 2,250 | 现货 | |
| 50 mg | ¥ 3,280 | 现货 | |
| 100 mg | ¥ 4,890 | 现货 | |
| 500 mg | ¥ 9,870 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 987 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | T-5224 is a selective inhibitor of the transcription factor c-Fos/activator protein (AP)-1 with anti-inflammatory effects. T-5224 specifically suppresses the DNA-binding activity of c-Fos/c-Jun, thereby inhibiting IL-1β-induced transcriptional upregulation of Mmp-3, Mmp-13, and Adamts-5, without affecting the binding activity of other transcription factors. T-5224 can be used in research on rheumatoid arthritis, osteoarthritis, and cartilage degeneration. |
| 靶点活性 | AP-1 (NIH3T3 cells):10 μM, MMP1 (SW982 cells):10 μM, β-hexosaminidase (RBL-2H3 cells):18.30 ± 1.48 µM |
| 体外活性 | 方法:人表皮角质形成细胞 NHEKs 加入 0.1-1 μM 浓度的 T-5224 ,处理 24 小时后,MTT 法检测细胞活力。 |
| 体内活性 | 方法:8~10 周雌性 BALB/c 小鼠构建 DNFB 模型,模型构建成功后,给药 1% T-5224/1% baricitinib/1% T-5224+1% baricitinib 软膏,每侧耳 25mg,1 次 / 天,共 8 天。 |
| 激酶实验 | The DNA binding activity of transcription factors was measured using the TransAM kits. Nuclear extracts containing factors such as c-Fos/AP-1, c-Jun/AP-1, ATF-2, C/EBPa, MyoD, Sp-1 or NF-kB/p65 and various concentrations of T-5224 were added in the multi-well plates precoated with respective consensus double-stranded (ds)DNA oligomers. After incubation for 1 h, the transcription factor bound to its respective consensus dsDNA sequences was detected by using antibodies reactive against the respective transcription factors according to the manufacturer's protocol [1]. |
| 细胞实验 | NIH/3T3 cells were transiently transfected with the luciferase reporter plasmids pAP-1-Luc (× 7 TGACTAA), pNF-kB-Luc (× 5 TGGGGACTTTCCGC) or control phRL-TK, and cultured overnight. Cells were incubated in 0.5% FBS/DMEM containing T-5224 for 1 h, and then stimulated with PMA (10 ng/ml) or TNFa (10 ng/ml), and then cultured for 3 h, followed by measurement of lysate by using dual-luciferase reporter assay system [1]. |
| 动物实验 | Mice were housed in an SPF (specific pathogen-free) grade environment and provided food and water ad libitum with a 12 h:12 h light/dark cycle. Male 8-week-old DBA/1J mice were immunized with bovine type II collagen emulsified in Freund's complete adjuvant on days 0 and 21. T-5224, MTX and LEF were orally administered once per day. Arthritis was assessed in a blind fashion for four paws per mouse using the following score: 0, uninvolved; 1, swelling of ≤2 toes or slight swelling in ankles and wrists; 2, swelling of ≥3 toes or moderate swelling in ankles and wrists; 3, extensive swelling of total paw. X-ray films of four paws taken using Softex were assessed for joint destruction in 2nd to 5th proximal interphalangeal joints and five metatarsophalangeal joints of four paws, the carpal joints of the forepaws, and the tarsal and calcaneal joints of the hind paws. Score was: 0, no change; 1, partial erosion; 2, complete erosion for joints; and 0, negative; 0.5, positive for osteoporosis. IL-1β (500 ng per unilateral hind paw) was administered into the footpads. The mice with ≥1 arthritis score were treated with either anti-TNFα antibody at 50 or 250 μg/mouse, intraperitoneally (i.p.) twice a week and/or with 3 mg/kg T-5224, orally once daily [1]. |
| 分子量 | 517.53 |
| 分子式 | C29H27NO8 |
| CAS No. | 530141-72-1 |
| Smiles | OC(=O)CCc1cc(ccc1OCc1ccc2c(c1)o[nH]c2=O)C(=O)c1ccc(OC2CCCC2)cc1O |
| 密度 | 1.376 g/cm3 (Predicted) |
| 存储 | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: Insoluble DMSO: 240 mg/mL (463.74 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (9.66 mM), Suspension. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多